Información: Esta es una versión obsoleta del modelo de datos. En la sección izquierda, bajo "Versiones", se encuentra el historial de versiones. Puede acceder a la versión actual a través del siguiente link: here.
Información:
Error:
ID
28429
Descripción
The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention; ODM derived from: https://clinicaltrials.gov/show/NCT00407771
Link
https://clinicaltrials.gov/show/NCT00407771
Palabras clave
Versiones (3)
- 12/1/18 12/1/18 -
- 14/1/18 14/1/18 -
- 14/1/18 14/1/18 -
Titular de derechos de autor
See clinicaltrials.gov
Subido en
12 de enero de 2018
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Eligibility Coronary Artery Disease NCT00407771
Eligibility Coronary Artery Disease NCT00407771
- StudyEvent: Eligibility
Similar models
Eligibility Coronary Artery Disease NCT00407771
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Patients Diabetic | Coronary Artery Disease | Percutaneous Coronary Intervention elective
Item
diabetic patients with coronary artery disease undergoing elective percutaneous coronary intervention
boolean
C0030705 (UMLS CUI [1,1])
C0241863 (UMLS CUI [1,2])
C1956346 (UMLS CUI [2])
C1532338 (UMLS CUI [3,1])
C0439608 (UMLS CUI [3,2])
C0241863 (UMLS CUI [1,2])
C1956346 (UMLS CUI [2])
C1532338 (UMLS CUI [3,1])
C0439608 (UMLS CUI [3,2])
ST segment elevation myocardial infarction
Item
ongoing st-segment elevation myocardial infarction (mi)
boolean
C1536220 (UMLS CUI [1])
abciximab
Item
administration of abciximab during the previous two weeks
boolean
C0288672 (UMLS CUI [1])
Creatinine measurement, serum
Item
serum creatinine more than 2.5 mg/dl (221 micro-mol/l)
boolean
C0201976 (UMLS CUI [1])
Hemorrhage | Bleeding tendency
Item
ongoing bleeding or bleeding diathesis
boolean
C0019080 (UMLS CUI [1])
C1458140 (UMLS CUI [2])
C1458140 (UMLS CUI [2])
Cerebrovascular accident
Item
previous stroke in the last six months
boolean
C0038454 (UMLS CUI [1])
Major surgery
Item
major surgery within the previous six weeks
boolean
C0679637 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count <100.000 per cubic mm
boolean
C0032181 (UMLS CUI [1])
Heparin, Low-Molecular-Weight | tirofiban | eptifibatide
Item
subjects who received low-molecular-weight heparin, tirofiban, or eptifibatide within the 10 hours prior to randomization
boolean
C0019139 (UMLS CUI [1])
C0247025 (UMLS CUI [2])
C0253563 (UMLS CUI [3])
C0247025 (UMLS CUI [2])
C0253563 (UMLS CUI [3])
Oral anticoagulants | Coumarins | PT-INR
Item
subjects on oral anticoagulation medication (coumarin derivatives) within the last 7 days unless pt-inr <1.5 times the control
boolean
C0354604 (UMLS CUI [1])
C0010207 (UMLS CUI [2])
C1821762 (UMLS CUI [3])
C0010207 (UMLS CUI [2])
C1821762 (UMLS CUI [3])